Neurology Medical News about Alzheimer's disease

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Few pharmacological options available for treating cognitive impairment associated with severe Alzheimer's disease
Drugs & Therapy Perspectives, 09/11/09

Severe Alzheimer's disease is a multifactorial illness, with cognitive impairment being only one of several problems that may be present. Approved pharmacological treatments for severe disease include donepezil (US) and memantine. While behavioural disturbances and intercurrent disorders can be pharmacologically treated, careful consideration should be applied as to whether these treatments have an acceptable benefit.

<< Previous
Rehabilitating torture survivors

Next >>
Fatigue-Based Subgroups of Breast Cancer Survivors With Insomnia

Does Diabetes Speed Up Memory Loss In Alzheimers Disease?
ScienceDaily, 10/28/09 Relevance Score: 70%

Activated astrocytes: a therapeutic target in Alzheimer's disease?
Expert Review of Neurotherapeutics, 11/19/09 Relevance Score: 69%

High Blood Pressure Likely in Alzheimers Offspring
MedLinePlus, 11/04/09 Relevance Score: 69%

New neuroimaging analysis technique identifies impact of Alzheimer's disease gene in healthy brains
EurekAlert, 11/18/09 Relevance Score: 68%

Protective Role For Copper In Alzheimers Disease
ScienceDaily, 10/14/09 Relevance Score: 68%